Arvinas (ARVN) EBIT Margin (2017 - 2026)

Arvinas (ARVN) recorded quarterly EBIT Margin of 408.97% in Q1 2026, up 47.92% quarter-over-quarter from 785.26% in Q4 2025, and down 44679.0% on a YoY basis from N/an in Q1 2025.

Arvinas (ARVN) EBIT Margin (2017 - 2026) Analysis & Trends

Arvinas' EBIT Margin history runs 10 years deep, the most recent figure standing at 408.97% for Q1 2026.

  • In Q1 2026, EBIT Margin fell 44679.0% year-over-year to 408.97%; the TTM figure through Mar 2026 stood at 283.78% (down 26139.0% YoY), while the FY2025 annual figure was 45.13%, up 4986.0% from the prior year.
  • EBIT Margin was 408.97% for Q1 2026 at Arvinas, up from 785.26% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 383.53% in Q4 2023 to a low of 785.26% in Q4 2025.
  • Historically, EBIT Margin has averaged 186.64% across 5 years, with a median of 194.67% in 2022.
  • The sharpest annual moves came in 2022 and 2025: EBIT Margin jumped 74896 bps in 2022, then sank 68695 bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 200.0% in 2022, then jumped by 292 bps to 383.53% in 2023, then slumped by 126 bps to 98.31% in 2024, then sank by 699 bps to 785.26% in 2025, then surged by 48 bps to 408.97% in 2026.
  • The last three EBIT Margin figures came in at 408.97% (Q1 2026), 785.26% (Q4 2025), and 104.53% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -6.43%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 38.10%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -408.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 -408.97%
Dec 31, 2025 -785.26%
Sep 30, 2025 -104.53%
Jun 30, 2025 -319.20%
Mar 31, 2025 37.82%
Dec 31, 2024 -98.31%
Sep 30, 2024 -58.89%
Jun 30, 2024 -63.40%
Mar 31, 2024 -329.25%
Dec 31, 2023 383.53%
Sep 30, 2023 -213.58%
Jun 30, 2023 -136.88%
Mar 31, 2023 -269.85%
Dec 31, 2022 -200.00%
Sep 30, 2022 -193.67%
Jun 30, 2022 -194.67%
Mar 31, 2022 -217.74%
Dec 31, 2021 -143.07%
Sep 30, 2021 -508.60%
Jun 30, 2021 -943.64%